NORDEA INVESTMENT MANAGEMENT AB
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1218210
STOCKHOLM, V7
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,132,937
-$190,595,598 QoQ
Shares Held
27,171
-93.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORDEA INVESTMENT MANAGEMENT AB holds $224,709,274 across 23 Biotechnology names. VRTX ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
94,322 | $72,876,949 | |
| 2 | RPRX |
Royalty Pharma plc
|
788,022 | $37,801,414 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
306,439 | $19,213,724 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
27,171 | $12,132,937 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
50,936 | $10,169,371 | |
| 6 | EXEL |
Exelixis, Inc.
|
201,553 | $8,644,607 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
113,902 | $6,434,323 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
51,821 | $5,461,932 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,132,937 | 27,171 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $202,728,535 | 447,169 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $141,415,329 | 361,085 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $10,912,742 | 24,512 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $11,371,452 | 23,455 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $137,896,156 | 342,429 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $133,333,784 | 286,690 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $165,568,309 | 353,235 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $138,557,356 | 331,469 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $130,746,370 | 321,331 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $107,824,437 | 310,072 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $101,680,171 | 288,938 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $84,509,965 | 268,226 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $86,449,180 | 299,360 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $78,975,219 | 272,761 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $70,514,566 | 250,238 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $70,384,652 | 269,704 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $58,631,882 | 266,994 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $43,022,261 | 237,181 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $42,869,965 | 212,617 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $41,371,912 | 192,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $32,857,168 | 139,025 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $29,008,808 | 106,603 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $52,253,476 | 179,992 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,267,006 | 59,958 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||